![Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah | Annals of Saudi Medicine Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah | Annals of Saudi Medicine](https://www.annsaudimed.net/cms/asset/6f304f17-df9d-4079-b754-a62feaebeebe/0646-oa_ig.jpg)
Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah | Annals of Saudi Medicine
![Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X19310448-ga1.jpg)
Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect
![Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-021-00570-x/MediaObjects/41575_2021_570_Fig1_HTML.png)
Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology
![Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/91dbf75b-2288-4086-9df9-adddee7ae55e/gr1_lrg.jpg)
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases
![Uptake of hepatitis B vaccination and its determinants among health care workers in a tertiary health facility in Enugu, South-East, Nigeria | BMC Infectious Diseases | Full Text Uptake of hepatitis B vaccination and its determinants among health care workers in a tertiary health facility in Enugu, South-East, Nigeria | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3191-9/MediaObjects/12879_2018_3191_Fig1_HTML.png)